University of California San Francisco

Qiao_Guilin
Guilin Qiao, PhD

Associate Professor of Surgery
Division of Surgical Oncology

Address

513 Parnassus Avenue, HSW, #1698
San Francisco, CA 94143
United States

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 8
    1. Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance.
      Wiley MB, Bauer J, Mehrotra K, Zessner-Spitzenberg J, Kolics Z, Cheng W, Castellanos K, Nash MG, Gui X, Kone L, Maker AV, Qiao G, Reddi D, Church DN, Kerr RS, Kerr DJ, Grippo PJ, Jung B| | PubMed
    2. LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer.
      Qiao G, Kone LB, Phillips EH, Lee SS, Brown GE, Khetani SR, Thakur A, Lum LG, Prabhakar BS, Maker AV| | PubMed
    3. Combination Immunotherapy With LIGHT and Interleukin-2 Increases CD8 Central Memory T-Cells In Vivo.
      Fernandez MF, Qiao G, Tulla K, Prabhakar BS, Maker AV| | PubMed
    4. MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer.
      Saini S, Sripada L, Tulla K, Qiao G, Kunda N, Maker AV, Prabhakar BS| | PubMed
    5. Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases.
      Qin J, Kunda NM, Qiao G, Tulla K, Prabhakar BS, Maker AV| | PubMed
    6. LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.
      Qiao G, Qin J, Kunda N, Calata JF, Mahmud DL, Gann P, Fu YX, Rosenberg SA, Prabhakar BS, Maker AV| | PubMed
    7. Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death.
      Qin J, Kunda N, Qiao G, Calata JF, Pardiwala K, Prabhakar BS, Maker AV| | PubMed
    8. Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis.
      Carr RM, Qiao G, Qin J, Jayaraman S, Prabhakar BS, Maker AV| | PubMed